WHO Validates Sinovac Covid-19 Vaccine for Emergency Use
The World Health Organisation (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.
"The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe," said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. "We urge manufacturers to participate in the COVAX Facility, share their know-how and data and contribute to bringing the pandemic under control."
The announcement comes as Africa records 4,879,291 cases of Covid-19 as of June 4, 2021, 131,528 cases proved fatal while 4,412,167 resulted in recovery.
As of October 23, confirmed cases of Covid-19 from 55 African countries reached 8,457,869 while over 106,010,059 vaccinations have been administered across the ... Read more »
The World Health Organisation (WHO) says the doses are needed in the next six weeks as second doses to all who received the first dose. This is to ensure the follow-up treatments ... Read more »
The World Health Organisation (WHO) Regional Office for Africa has provided clarification on the issue of expiry dates of Covid-19 vaccines in general, and specifically on ... Read more »
The Sinovac company website page.